115 related articles for article (PubMed ID: 37724007)
21. Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines.
Nam A; Song WJ; An JH; Rebhun RB; Youn HY; Seo KW
Vet Comp Oncol; 2022 Dec; 20(4):778-787. PubMed ID: 35521940
[TBL] [Abstract][Full Text] [Related]
22. Hydroxychloroquine Destabilizes Phospho-S6 in Human Renal Carcinoma Cells.
Lee HO; Mustafa A; Hudes GR; Kruger WD
PLoS One; 2015; 10(7):e0131464. PubMed ID: 26134285
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
Lin YC; Lin JF; Wen SI; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Kaohsiung J Med Sci; 2017 May; 33(5):215-223. PubMed ID: 28433067
[TBL] [Abstract][Full Text] [Related]
24. GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
Cournoyer S; Addioui A; Belounis A; Beaunoyer M; Nyalendo C; Le Gall R; Teira P; Haddad E; Vassal G; Sartelet H
BMC Cancer; 2019 Oct; 19(1):1018. PubMed ID: 31664947
[TBL] [Abstract][Full Text] [Related]
25. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.
Ong SM; Saeki K; Tanaka Y; Nishimura R; Nakagawa T
Vet J; 2016 Dec; 218():51-59. PubMed ID: 27938709
[TBL] [Abstract][Full Text] [Related]
26. Indentification of breast cancer subtypes sensitive to HCQ-induced autophagy inhibition.
Wang P; Du Y; Wang J
Pathol Res Pract; 2019 Oct; 215(10):152609. PubMed ID: 31488317
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the protective effects of all-trans-astaxanthin on canine osteosarcoma cell lines.
Wakshlag JJ; Balkman CA; Morgan SK; McEntee MC
Am J Vet Res; 2010 Jan; 71(1):89-96. PubMed ID: 20043787
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
[TBL] [Abstract][Full Text] [Related]
29. The selective inhibitor of nuclear export (SINE) verdinexor exhibits biologic activity against canine osteosarcoma cell lines.
Breitbach JT; Louke DS; Tobin SJ; Watts MR; Davies AE; Fenger JM
Vet Comp Oncol; 2021 Jun; 19(2):362-373. PubMed ID: 33438820
[TBL] [Abstract][Full Text] [Related]
30. Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model.
Ong SM; Saeki K; Kok MK; Tanaka Y; Choisunirachon N; Yoshitake R; Nishimura R; Nakagawa T
Res Vet Sci; 2017 Aug; 113():130-135. PubMed ID: 28957780
[TBL] [Abstract][Full Text] [Related]
31. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms.
Ferreira PMP; Sousa RWR; Ferreira JRO; Militão GCG; Bezerra DP
Pharmacol Res; 2021 Jun; 168():105582. PubMed ID: 33775862
[TBL] [Abstract][Full Text] [Related]
32. The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomas.
Gola C; Licenziato L; Accornero P; Iussich S; Morello E; Buracco P; Modesto P; Aresu L; De Maria R
Vet Comp Oncol; 2022 Dec; 20(4):890-900. PubMed ID: 36054794
[TBL] [Abstract][Full Text] [Related]
33. Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines.
Yang YT; Yuzbasiyan-Gurkan V
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012610
[TBL] [Abstract][Full Text] [Related]
34. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.
Rangwala R; Chang YC; Hu J; Algazy KM; Evans TL; Fecher LA; Schuchter LM; Torigian DA; Panosian JT; Troxel AB; Tan KS; Heitjan DF; DeMichele AM; Vaughn DJ; Redlinger M; Alavi A; Kaiser J; Pontiggia L; Davis LE; O'Dwyer PJ; Amaravadi RK
Autophagy; 2014 Aug; 10(8):1391-402. PubMed ID: 24991838
[TBL] [Abstract][Full Text] [Related]
35. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells.
Ong SM; Saeki K; Kok MK; Nakagawa T; Nishimura R
J Vet Med Sci; 2019 Aug; 81(8):1182-1190. PubMed ID: 31308291
[TBL] [Abstract][Full Text] [Related]
36. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
York D; Withers SS; Watson KD; Seo KW; Rebhun RB
Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
[TBL] [Abstract][Full Text] [Related]
37. Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.
Patatsos K; Shekhar TM; Hawkins CJ
Vet Comp Oncol; 2018 Dec; 16(4):544-553. PubMed ID: 29998615
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs.
Ashton JA; Farese JP; Milner RJ; Lee-Ambrose LM; van Gilder JM
Am J Vet Res; 2005 May; 66(5):885-91. PubMed ID: 15934617
[TBL] [Abstract][Full Text] [Related]
39. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
Marley K; Helfand SC; Edris WA; Mata JE; Gitelman AI; Medlock J; Séguin B
BMC Vet Res; 2013 Jan; 9():15. PubMed ID: 23331343
[TBL] [Abstract][Full Text] [Related]
40. In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells.
Hong SH; Kadosawa T; Nozaki K; Mochizuki M; Matsunaga S; Nishimura R; Sasaki N
Am J Vet Res; 2000 Jan; 61(1):69-73. PubMed ID: 10630782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
